Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease
Qing Zhou,Hongying Wang,Daniella M. Schwartz,Monique Stoffels,Yong Hwan Park,Yuan Zhang,Dan Yang,Erkan Demirkaya,Masaki Takeuchi,Wanxia Li Tsai,Jonathan J. Lyons,Xiaomin Yu,Claudia Ouyang,Celeste Chen,David T. Chin,Kristien J. M. Zaal,Settara C. Chandrasekharappa,Eric P. Hanson,Zhen Yu,James C. Mullikin,Sarfaraz Hasni,Ingrid E. Wertz,Amanda K. Ombrello,Deborah L. Stone,Patrycja Hoffmann,Anne Jones,Beverly K. Barham,Helen L. Leavis,Annet Van Royen-Kerkof,Cailin H. Sibley,Ezgi Deniz Batu,Ahmet Gül,Richard M. Siegel,Manfred Boehm,Joshua D. Milner,Seza Ozen,Massimo Gadina,Jae Jin Chae,Ronald M. Laxer,Daniel L. Kastner,Ivona Aksentijevich +40 more
Reads0
Chats0
TLDR
A new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-κB regulatory protein A20, in six unrelated families with early-onset systemic inflammation is described, which resembles Behçet's disease.Abstract:
Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity. Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-κB regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behcet's disease, which is typically considered a polygenic disorder with onset in early adulthood. A20 is a potent inhibitor of the NF-κB signaling pathway. Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of IκBα and nuclear translocation of the NF-κB p65 subunit together with increased expression of NF-κB-mediated proinflammatory cytokines. A20 restricts NF-κB signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-κB-dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.read more
Citations
More filters
Journal ArticleDOI
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
TL;DR: The NF-κB was discovered 30 years ago as a rapidly inducible transcription factor and has been found to have a broad role in gene induction in diverse cellular responses, particularly throughout the immune system as mentioned in this paper.
Journal ArticleDOI
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Mehdi Bouhaddou,Danish Memon,Bjoern Meyer,Kris M. White,Veronica V. Rezelj,Miguel Correa Marrero,Benjamin J. Polacco,James E. Melnyk,Svenja Ulferts,Robyn M. Kaake,Jyoti Batra,Alicia L. Richards,Erica Stevenson,David E. Gordon,Ajda Rojc,Kirsten Obernier,Jacqueline M. Fabius,Margaret Soucheray,Lisa Miorin,Elena Moreno,Cassandra Koh,Quang Dinh Tran,Alexandra Hardy,Rémy Robinot,Thomas Vallet,Benjamin E. Nilsson-Payant,Claudia Hernandez-Armenta,Alistair Dunham,Sebastian Weigang,Julian Knerr,Maya Modak,Diego Quintero,Yuan Zhou,Aurelien Dugourd,Alberto Valdeolivas,Trupti Patil,Qiongyu Li,Ruth Hüttenhain,Merve Cakir,Monita Muralidharan,Minkyu Kim,Gwendolyn M. Jang,Beril Tutuncuoglu,Joseph Hiatt,Jeffrey Z. Guo,Jiewei Xu,Sophia Bouhaddou,Christopher J.P. Mathy,Anna Gaulton,Emma J. Manners,Eloy Felix,Ying Shi,Marisa Goff,Jean K. Lim,Timothy McBride,Michael C. O’Neal,Yiming Cai,Jason C.J. Chang,David J. Broadhurst,Saker Klippsten,Emmie de Wit,Andrew R. Leach,Tanja Kortemme,Brian K. Shoichet,Melanie Ott,Julio Saez-Rodriguez,Benjamin R. tenOever,R. Dyche Mullins,Elizabeth R. Fischer,Georg Kochs,Robert Grosse,Adolfo García-Sastre,Marco Vignuzzi,Jeffery R. Johnson,Kevan M. Shokat,Danielle L. Swaney,Pedro Beltrao,Nevan J. Krogan +77 more
TL;DR: A quantitative mass spectrometry-based phosphoproteomics survey of SARS-CoV-2 infection in Vero E6 cells reveals dramatic rewiring of phosphorylation on host and viral proteins, revealing potential COVID-19 therapies.
Journal ArticleDOI
Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome.
TL;DR: The key molecular mechanisms that contribute to the self-limiting nature of inflammatory signaling are discussed, with emphasis on the negative regulation of the NF-κB pathway and the NLRP3 inflammasome.
Journal ArticleDOI
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study.
TL;DR: This review attempts to summarize the current knowledge and updates on the mechanisms of NF-κB pathway regulation and the potential therapeutic application of inhibition of NF -κB signaling in cancer and inflammatory diseases.
Journal ArticleDOI
Post-Translational Modification Control of Innate Immunity
TL;DR: The roles ofPTMs in controlling PRR-triggered innate immunity and inflammatory responses are focused on and the emerging roles of PTMs in the pathogenesis and potential treatment of infectious and inflammatory immune diseases are discussed.
References
More filters
Journal ArticleDOI
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll,Avril A. B. Robertson,Jae Jin Chae,Sarah C. Higgins,Raúl Muñoz-Planillo,Marco Inserra,Irina Vetter,Lara S. Dungan,Brian G. Monks,Andrea Stutz,Daniel E. Croker,Mark S. Butler,Moritz Haneklaus,Caroline E. Sutton,Gabriel Núñez,Eicke Latz,Daniel L. Kastner,Kingston H. G. Mills,Seth L. Masters,Kate Schroder,Mark E. Cooper,Luke A. J. O'Neill +21 more
TL;DR: MCC950 treatment rescued neonatal lethality in a mouse model of CAPS and was active in ex vivo samples from individuals with Muckle–Wells syndrome, and is a potential therapeutic for NLRP3-associated syndromes, and a tool for further study of theNLRP3 inflammasome in human health and disease.
Journal ArticleDOI
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Ingrid E. Wertz,Karen O'Rourke,Honglin Zhou,Michael Eby,L. Aravind,Somasekar Seshagiri,Ping Wu,Christian Wiesmann,Rohan T. Baker,David L. Boone,Averil Ma,Eugene V. Koonin,Vishva M. Dixit +12 more
TL;DR: A novel ubiquitin ligase domain is defined and two sequential mechanisms by which A20 downregulates NF-κB signalling are identified, both of which participate in mediating a distinct regulatory effect.
Journal ArticleDOI
Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
TL;DR: A20 is critical for limiting inflammation by terminating TNF-induced NF-kappaB responses in vivo and is associated with severe inflammation and cachexia in mice deficient for A20.
Journal ArticleDOI
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair,Kristina Callis Duffin,Cynthia Helms,Jun Ding,Philip E. Stuart,David E. Goldgar,Johann E. Gudjonsson,Yun Li,Trilokraj Tejasvi,Bing Jian Feng,Andreas Ruether,Stefan Schreiber,Michael Weichenthal,Dafna D. Gladman,Proton Rahman,Steven J. Schrodi,Sampath Prahalad,Sampath Prahalad,Stephen L. Guthery,Stephen L. Guthery,Judith Fischer,Wilson Liao,Pui-Yan Kwok,Alan Menter,G. Mark Lathrop,Carol Wise,Ann B. Begovich,John J. Voorhees,James T. Elder,James T. Elder,Gerald G. Krueger,Anne M. Bowcock,Gonçalo R. Abecasis +32 more
TL;DR: The results provide strong support for the association of at least seven genetic loci and psoriasis (each with combined P < 5 × 10−8) and suggest priority targets for study in other auto-immune disorders.
Journal ArticleDOI
The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
Geun-Shik Lee,Naeha Subramanian,Andrew I. Kim,Ivona Aksentijevich,Raphaela Goldbach-Mansky,David B. Sacks,Ronald N. Germain,Daniel L. Kastner,Jae Jin Chae +8 more
TL;DR: Findings indicate that Ca2+ and cAMP are two key molecular regulators of the NLRP3 inflammasome that have critical roles in the molecular pathogenesis of CAPS.
Related Papers (5)
A20: linking a complex regulator of ubiquitylation to immunity and human disease
Averil Ma,Barbara A. Malynn +1 more
Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency
Bertrand Boisson,Emmanuel Laplantine,Carolina Prando,Silvia Giliani,Elisabeth Israelsson,Zhaohui Xu,Avinash Abhyankar,Laura Israel,Laura Israel,Giraldina Trevejo-Nunez,Dusan Bogunovic,Alma-Martina Cepika,Donna A. MacDuff,Maya Chrabieh,Maya Chrabieh,Marjorie Hubeau,Marjorie Hubeau,Fanny Bajolle,Marianne Debré,Evelina Mazzolari,Donatella Vairo,Fabrice Agou,Herbert W. Virgin,Xavier Bossuyt,Caroline Rambaud,Fabio Facchetti,Damien Bonnet,Damien Bonnet,Pierre Quartier,Pierre Quartier,Jean-Christophe Fournet,Jean-Christophe Fournet,Virginia Pascual,Damien Chaussabel,Damien Chaussabel,Luigi D. Notarangelo,Anne Puel,Anne Puel,Alain Israël,Jean-Laurent Casanova,Capucine Picard +40 more